Contract 36F79721D0111
Mainpointe Pharmaceuticals Llc · Department Of Veterans Affairs · February 18, 2021
Mainpointe Pharmaceuticals Llc was awarded a federal contract by Department Of Veterans Affairs on February 18, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $4.77 million.
Contract details
- PIID
- 36F79721D0111
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- February 18, 2021
- Latest action
- March 18, 2026
Description
POC UPDATE.
Modification timeline
-
March 18, 2026Mod P00004$0
-
February 18, 2026Mod P00003TEMPORARY CONTRACT EXTENSION$0
-
July 16, 2024Mod P00002ADDITION.$0
-
June 21, 2023Mod P00001POC AND SIGNATORY AUTHORITY FORM UPDATE$0
-
February 18, 2021Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0111?
Contract 36F79721D0111 is a federal contract awarded to Mainpointe Pharmaceuticals Llc by Department Of Veterans Affairs on February 18, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79721D0111?
Mainpointe Pharmaceuticals Llc won contract 36F79721D0111 from Department Of Veterans Affairs.
How much is contract 36F79721D0111 worth?
Contract 36F79721D0111 has obligated $0 to date but carries a potential ceiling of $4.77 million if fully funded and all options are exercised.